|
參考文獻 1. Liu S.Y. Wang J.Y. Shyu Y.T. Song L.M. Studies on Yams (Dioscorea spp.) in Taiwan. J.Chin.Med. 6: 111-126, 1995. 2. 後漢作品,神農本草經,佚。孫星衍、孫馮翼重輯:神農本草經(1799) ,自由出版社重印,台北 1969;卷1:18。 3. 明,李時珍:本草綱目(1593),宏業書局印行,台北 1979;中冊119-120. 4. 許鴻源:中藥材之研究,新醫藥出版社,台北 1980: 180。 5. Shuying H. Tong Z. Shuru W. Study on chemistry and antioxidation activity of water-soluble polysaccharides of rhizoma Dioscoreae Oppositae. J. Chin. Phar. Uni. 25(6): 369-372, 1994. 6. Hikino H. Konno C. Takahashi M. Murakami M. Kato Y. Karikura M. Hayashi T. Isolation and hypoglycemic activity of dioscorans A, B, C, D, E, and F; glycans of Dioscorea japonica rhizophors. Planta Medica. (3): 168-171, 1986. 7. Ogra, P.L. (ed.): Mucosal immunology. San Diago: Academic press, 1999. 8. Burgess AW. Camakaris J. Metcalf D. Purification and properties of colony-stimulating factor from mouse lung-conditioned medium. Journal of Biological Chemistry. 252(6):1998-2003, 1977 9. Trowbridge IS. Mitogenic properties of lectin and its chemical dervatives. Proc Natl Acad Sci U S A. 70(12): 3650-3654, 1973. 10. Stobo JD. Phytohemagglutin and concanavalin A: probes for murine ''''''''T'''''''' cell activivation and differentiation. Transplantation Reviews. 11:60-86, 1972. 11. Kirkwood JM. Ernstoff MS. Interferons in the treatment of human cancer. J Clin Oncol. 2(4): 336-352, 1984. 12. J Clin Oncol. Ouellette, A.J. and Selsted, M.E. Paneth cell defensins: endogenous peptide components of intestinal host defense. FASEB Journal 10(11): 1280-1289, 1996. 13. Ouellette AJ. Greco RM. James M. Frederick D. Naftilan J. Fallon JT. Developmental regulation of cryptdin, a corticostatin/defensin precursor mRNA in mouse small intestinal crypt epithelium. Journal of Cell Biology. 108(5): 1687-1695, 1989. 14. Ouellette A.J. Paneth cells and innate immunity in the crypt microenvironment. Gastroenterology 113(5): 1779-1884, 1997. 15. Kagan B.L. Ganz T. Lehrer R.I. Defensins: a family of antimicrobial and cytotoxic peptides. Toxicology 87(1-3): 131-149, 1994. 16. Selsted M.E. Miller S.I. Henschen A.H. Ouellette A.J. Enteric defensins: antibiotic peptide components of intestinal host defense. Journal of Cell Biology 118(4): 929-936, 1992. 17. Qu XD. Lloyd KC. Walsh JH. Lehrer RI. Secretion of type II phospholipase A2 and cryptdin by rat small intestinal Paneth cells. Infection & Immunity. 64(12): 5161-5165, 1996. 18. Ouellette AJ. Hsieh MM. Nosek MT. Cano-Gauci DF. Huttner KM. Buick RN. Selsted ME. Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms. Infection & Immunity. 62(11): 5040-5047, 1994. 19. Husby S. Normal immune responses to ingested foods. Journal of Pediatric Gastroenterology & Nutrition. 30: S13-19. 2000. 20. Mayer L. Mucosal immunity and gastrointestinal antigen processing. Journal of Pediatric Gastroenterology & Nutrition. 30: S4-12, 2000. 21. McGhee J.R. Kiyono H. The mucosal immune system. In: Anonymous Fundamental immunology, Paul W.E. (ed.) Philadelphia: Lippincott- Ravan, 1999, pp 909-945. 22. Kantele A. Westerholm M. Kantele JM. Makela PH. Savilahti E. Homing potentials of circulating antibody-secreting cells after administration of oral or parenteral protein or polysaccharide vaccine in humans. Vaccine. 17(3): 229-236, 1999. 23. MacDonald TT. Effector and regulatory lymphoid cells and cytokines in mucosal sites. Current Topics in Microbiology & Immunology. 236: 113-135, 1999. 24. Janoff EN. Fasching C. Orenstein JM. Rubins JB. Opstad NL. Dalmasso AP. Killing of Streptococcus pneumoniae by capsular polysaccharide specific polymeric IgA, complement, and phagocytes. Journal of Clinical Investigation. 104(8): 1139-1147, 1999. 25. Boyaka PN. Marinaro M. Vancott JL. Takahashi I. Fujihashi K. Yamamoto M. van Ginkel FW. Jackson RJ. Kiyono H. McGhee JR. Strategies for mucosal vaccine development. American Journal of Tropical Medicine & Hygiene. 60(4): 35-45, 1999. 26. Garg M. Luo W. Kaplan AM. Bondada S. Cellular basis of decreased immune responses to pneumococcal vaccines in aged mice. Infection & Immunity. 64(11): 4456-4462, 1996. 27. Van den Dobbelsteen GP. Van Rees EP. Mucosal immune responses to pneumococcal polysaccharides: implications for vaccination. Trends in Microbiology. 3(4): 155-159, 1995. 28. Flanagan MP. Michael JG. Oral immunization with a Streptococcal pneumoniae polysaccharide conjugate vaccine in enterocoated microparticles induces serum antibodies against type specific polysaccharides. Vaccine. 17(1): 72-81, 1999. 29. VanCott JL. Kobayashi T. Yamamoto M. Pillai S. McGhee J.R. Kiyono H. Induction of pneumococcal polysaccharide-specific mucosal immune responses by oral immunization. Vaccine, 14: 392-398, 1996. 30. Buchanan RM. Arulanandam BP. Metzger DW. IL-12 enhances antibody responses to T-independent polysaccharide vaccines in the absence of T and NK cells. Journal of Immunology. 161(10): 5525-5533, 1998. 31. Yamamoto M. McDaniel LS. Kawabata K. Briles DE. Jackson RJ. McGhee JR. Kiyono H. Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection. Infection & Immunity. 65(2): 640-644, 1997. 32. Araghiniknam M. Chung S. Nelson-White T. Eskelson C. Watson R.R. Antioxidant activity of dioscorea and dehydro-epiandrosterone (DHEA) in older humans. Life Sciences, 59: 147-157, 1996. 33. Li C. Yu B. Liu M. Hui Y. Synthesis of diosgenyl alpha-L-rhamno-pyranosyl-(1-->2)-[beta-D-glucopyranosyl-(1-->3)]-beta-D-glucopyranoside (gracillin) and related saponins. Carbohydrate. Research, 306: 189-195, 1998. 34. Aradhana. Rao AR. Kale RK. Diosgenin--a growth stimulator of mammary gland of ovariectomized mouse. Indian Journal of Experimental Biology. 30(5): 367-370, 1992. 35. Van der Kooy D. Weiss S. Why stem cells? Science. 287(5457): 1439-1441, 2000. 36. Kuhn HG. Dickinson-Anson H. Gage FH. Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. Journal of Neuroscience. 16(6): 2027-2033, 1996. 37. Weissman L. Stem cells: units of development, units of regeneration, and units in evolution. Cell. 100(1): 157-168, 2000. 38. Flax JD. Aurora S. Yang C. Simonin C. Wills AM. Billinghurst LL. Jendoubi M. Sidman RL. Wolfe JH. Kim SU. Snyder EY. Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nature Biotechnology. 16(11): 1033-1039, 1998. 39. Gritti A. Cova L. Parati EA. Galli R. Vescovi AL. Basic fibroblast growth factor supports the proliferation of epidermal growth factor-generated neuronal precursor cells of the adult mouse CNS. Neuroscience Letters. 185(3): 151-154, 1995. 40. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 276(5309): 71-74, 1997. 41. Martin I. Muraglia A. Campanile G. Cancedda R. Quarto R. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology. 138(10): 4456-4462, 1997. 42. Woodbury D. Schwarz EJ. Prockop DJ. Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. Journal of Neuroscience Research. 61(4): 364-370, 2000. 43. Scheven BA. Milne JS. Dehydroepiandrosterone (DHEA) and DHEA-S interact with 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) to stimulate human osteoblastic cell differentiation. Life Sciences. 62(1): 59-68, 1998. 44. Cheng SL. Yang JW. Rifas L. Zhang SF. Avioli LV. Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology. 134(1): 277-286, 1994. 45. QU Q. PH M. Kapanen A. Dahllund J. Salo J. Vaananen H.K. Harkonen P. Estrogen enhances differentiation on osteoblasts in mouse bone marrow culture. Bone 22: 201-209, 1998. 46. Schrimsher J.L. Rose K. Simona M.G. Wingfield P. Characterization of human and mouse granulocyte-macrophage-colony-stimulating factors derived from Escherichia coli. Biochemical Journal, 247: 195-199, 1987. 47. DeLamarter J.F. Mermod J.J. Liang C.M. Eliason J.F. Thatcher D.R. Recombinant murine GM-CSF from E. coli has biological activity and is neutralized by a specific antiserum. EMBO Journal, 4: 2575-2581, 1985. 48. Metcalf D. Burgess A.W. Johnson G.R. Nicola N.A. Nice E.C. DeLamarter J. Thatcher D.R. Mermod J.J. In vitro actions on hemopoietic cells of recombinant murine GM-CSF purified after production in Escherichia coli: comparison with purified native GM-CSF. Journal of Cellular Physiology, 128: 421-431, 1986. 49. Huttner K.M. Selsted M.E. Ouellette A.J. Structure and diversity of the murine cryptdin gene family. Genomics 19(3): 448-553, 1994. 50. Liu, F., Ooi, V.E., and Fung, M.C. Analysis of immunomodulating cytokine mRNAs in the mouse induced by mushroom polysaccharides. Life Sciences, 64: 1005-1011, 1999. 51. Fan J.Y. Boyce C.S. Cuff C.F. T-Helper 1 and T-helper 2 cytokine responses in gut-associated lymphoid tissue following enteric reovirus infection. Cellular Immunology, 188: 55-63, 1998. 52. Cowdery J.S. McKiernan F.E. Analysis of T cell and B cell function in Peyer''''''''s patch and lamina propria of New Zealand Black and DBA/2 mice. Journal of Immunology, 136: 4070-4074. 1986. 53. DeWitt RC. Wu Y. Renegar KB. King BK. Li J. Kudsk KA. Bombesin recovers gut-associated lymphoid tissue and preserves immunity to bacterial pneumonia in mice receiving total parenteral nutrition. Annals of Surgery. 231(1): 1-8, 2000. 54. Uchida T. Goto S. Oral delivery of poly (lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation: particle size study. Biological & Pharmaceutical Bulletin. 17(9): 1272-1276, 1994. 55. Elson C.O. Ealding W. Lefkowitz J. A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions. Journal of immunological methods, 67: 101-108. 1984. 56. Katz J.M. Lu X. Young S.A. Galphin J.C. Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated Influenza virus vaccine. Journal of infectious disease, 175: 352-363, 1997. 57. Rafati H. Lavelle EC. Coombes AG. Stolnik S. Holland J. Davis SS. The immune response to a model antigen associated with PLG microparticles prepared using different surfactants. Vaccine. 15(17-18): 1888-1897, 1997. 58. Konradsen, H.B., Sorensen, U.B. and Henrichsen, J. A modified enzyme-linked immunosorbent assay for measuring type-specific anti-pneumococcal capsular polysaccharide antibodies. Journal of immunological methods, 164: 13-20. 1993. 59. Sabokbar A. Millett PJ. Myer B. Rushton N. A rapid, quantitative assay for measuring alkaline phosphatase activity in osteoblastic cells in vitro. Bone & Mineral. 27(1): 57-67, 1994. 60. Hang Y.Y. Determination of the content of main constituents and pharmacological experiments of Dioscorea japonica in China. Journal of Plant resource and environment, 5: 5-8, 1996. 61. Haq TA. Mason HS. Clements JD. Arntzen CJ. Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science. 268(5211): 714-716, 1995. 62. Schaefer W. Goerz A. Kahl G. T DNA integration and expression in a monocot crop plant after induction of agrobacterium. Nature 327(6122): 529-532, 1987. 63. Strober W. Kelsall B. Marth T. Oral tolerance. Journal of Clinical Immunology. 18(1): 1-30, 1998. 64. Elson CO. Ealding W. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. Journal of Immunology. 132(6): 2736-2741, 1984. 65. Faria AM. Garcia G. Rios MJ. Michalaros CL. Vaz NM. Decrease in susceptibility to oral tolerance induction and occurrence of oral immunization to ovalbumin in 20-38-week-old mice. The effect of interval between oral exposures and rate of antigen intake in the oral immunization. Immunology. 78(1): 147-151, 1993. 66. Faria AM. Weiner HL. Oral tolerance: mechanisms and therapeutic applications. Advances in Immunology. 73:153-264, 1999. 67. Romero-Steiner S. Musher DM. Cetron MS. Pais LB. Groover JE. Fiore AE. Plikaytis BD. Carlone GM. Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clinical Infectious Diseases. 29(2): 281-288, 1999. 68. Husband AJ. Bao S. Beagley KW. Analysis of the mucosal microenvironment: factors determining successful responses to mucosal vaccines. Veterinary Immunology & Immunopathology. 72(1-2): 135-142, 1999. 69. Strober W. Interactions between epithelial cells and immune cells in the intestine. Annals of the New York Academy of Sciences. 859:37-45, 1998. 70. 潘宜欣。(2000) 靈芝多糖於腸道免疫系統作用的研究 國立陽明大學生物藥學研究所碩士論文。 71. Xu-Amano J. Jackson RJ. Fujihashi K. Kiyono H. Staats HF. McGhee JR. Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin. Vaccine. 12(10): 903-911, 1994. 72. Sieff CA. Emerson SG. Donahue RE. Nathan DG. Wang EA. Wong GG. Clark SC. Human recombinant granulocyte- macrophage colony- stimulating factor: a multilineage hematopoietin. Science. 230(4730): 1171-1173, 1985. 73. 李樹英 五種山藥對小鼠免疫功能影響的比較研究 河南中醫, 12: 23-24, 1992. 74. 周可范 山藥的研究概況 中草藥, 24: 158-160, 1993. 75. 苗明三 懷山藥對免疫功能的影響 河南中醫, 16: 349-350, 1996. 76. Sakushima J. Nose M. Ogihara Y. Effect of hachimi-jio-gan on immunoglobulin A producing cells in Peyer''''''''s patch by oral administration. Biological & Pharmaceutical Bulletin. 20(11): 1175-1177, 1997. 77. Kumazawa Y. Mizunoe K. Otsuka Y. Immunostimulating polysaccharide separated from hot water extract of Angelica acutiloba Kitagawa (Yamato tohki). Immunology. 47(1): 75-83, 1982. 78. Han SB. Kim YH. Lee CW. Park SM. Lee HY. Ahn KS. Kim IH. Kim HM. Characteristic immunostimulation by angelan isolated from Angelica gigas Nakai. Immunopharmacology. 40(1): 39-48, 1998. 79. Tsukamoto T., Ueno Y, Ohta Z. Glycosides of Diosocrea tokoro I. Dioscin, dioscoreasapotoxin and diosgenin. J. Pharm Soc Jpn 56: 135, 1936. 80. Zava DT. Dollbaum CM. Blen M. Estrogen and progestin bioactivity of foods, herbs, and spices. Experimental Biology & Medicine. 217(3): 369-378, 1998. 81. Evans TG. Judd ME. Dowell T. Poe S. Daynes RA. Araneo BA. The use of oral dehydroepiandrosterone sulfate as an adjuvant in tetanus and influenza vaccination of the elderly. Vaccine. 14(16): 1531-1537, 1996. 82. Caffrey RE. Kapasi ZF. Haley ST. Tew JG. Szakal AK. DHEAS enhances germinal center responses in old mice. Advances in Experimental Medicine & Biology. 355: 225-229, 1994. 83. Ronald, F. Dehydroepiandrosterone in Systemic Lupus Erythe-matosus Rheumatic disease. Clinics of North America. 26: 349-363, 2000. 84. Catalina F. Kumar V. Milewich L. Bennett M. Food restriction-like effects of dehydroepiandrosterone: decreased lymphocyte numbers and functions with increased apoptosis. Experimental Biology & Medicine. 221(4): 326-335, 1999. 85. Qu Q. Harkonen PL. Monkkonen J. Vaananen HK. Conditioned medium of estrogen-treated osteoblasts inhibits osteoclast maturation and function in vitro. Bone. 25(2): 211-215, 1999. 86. Paula Kiberstis, Orla Smith, and Colin Norman. Bone Health in the Balance. Science 289: 1497, 2000. 87. Locklin RM. Williamson MC. Beresford JN. Triffitt JT. Owen ME. In vitro effects of growth factors and dexamethasone on rat marrow stromal cells. Clinical Orthopaedics & Related Research. (313): 27-35, 1995. 88. Nawata H. Tanaka S. Tanaka S. Takayanagi R. Sakai Y. Yanase T. Ikuyama S. Haji M. Aromatase in bone cell: association with osteoporosis in postmenopausal women. Journal of Steroid Biochemistry & Molecular Biology. 53(1-6): 165-174, 1995. 89. Higdon K. Scott A. Tucci M. Benghuzzi H. Tsao A. Puckett A. Cason Z. Hughes J. The use of estrogen, DHEA, and diosgenin in a sustained delivery setting as a novel treatment approach for osteoporosis in the ovariectomized adult rat model. Biomedical Sciences Instrumentation. 37: 281-286, 2001. 90. Martel C. Sourla A. Pelletier G. Labrie C. Fournier M. Picard S. Li S. Stojanovic M. Labrie F. Predominant androgenic component in the stimulatory effect of dehydroepiandrosterone on bone mineral density in the rat. Journal of Endocrinology. 157(3): 433-442, 1998. 91. Ueno K. Katayama T. Miyamoto T. Koshihara Y. Interleukin-4 enhances in vitro mineralization in human osteoblast-like cells. Biochemical & Biophysical Research Communications. 189(3): 1521-1526, 1992. 92. Orwoll E. Ettinger M. Weiss S. Miller P. Kendler D. Graham J. Adami S. Weber K. Lorenc R. Pietschmann P. Vandormael K. Lombardi A. Alendronate for the treatment of osteoporosis in men. New England Journal of Medicine. 343(9): 604-610, 2000. 93. Fisher JE. Rogers MJ. Halasy JM. Luckman SP. Hughes DE. Masarachia PJ. Wesolowski G. Russell RG. Rodan GA. Reszka AA. Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proceedings of the National Academy of Sciences of the United States of America. 96(1): 133-138, 1999. 94. Tushinski RJ. Stanley ER. The regulation of mononuclear phagocyte entry into S phase by the colony stimulating factor CSF-1. Journal of Cellular Physiology. 122(2): 221-228, 1985. 95. Yamada M. Suzu S. Akaiwa E. Wakimoto N. Hatake K. Motoyoshi K. Shimamura S. Properties of primary murine stroma induced by macrophage colony-stimulating factor. Journal of Cellular Physiology. 173(1): 1-9, 1997. 96. Beneytout JL. Nappez C. Leboutet MJ. Malinvaud G. A plant steroid, diosgenin, a new megakaryocytic differentiation inducer of HEL cells. Biochemical & Biophysical Research Communi-cations. 207(1): 398-404, 1995. 97. Reynolds BA. Weiss S. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Developmental Biology. 175(1): 1-13, 1996. 98. Bjornson CR. Rietze RL. Reynolds BA. Magli MC. Vescovi AL. Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science. 283(5401): 534-537, 1999. 99. Olanow CW. Kordower JH. Freeman TB. Fetal nigral transplantation as a therapy for Parkinson''''''''s disease. Trends in Neurosciences. 19(3): 102-109, 1996. 100. Svendsen CN. Smith AG. New prospects for human stem-cell therapy in the nervous system. Trends in Neurosciences. 22(8): 357-364, 1999. 101. Gage FH. Cell therapy. Nature. 392: 18-24, 1998. 102. Khatim MS. Al-Mahmood HA. Gumaa KA. Modulation of rat pancreatic islet cell replication and insulin release by glibenclamide. FEBS Letters. 177(1): 135-7, 1984. 103. Jackson RA. Hawa MI. Jaspan JB. Sim BM. Disilvio L. Featherbe D. Kurtz AB. Mechanism of metformin action in non-insulin-dependent diabetes. Diabetes. 36(5): 632-640, 1987.
|